Regulations: FDA OPDP

FDA OPDP Boxed Warning Marketing Standards

Promotion of drugs with a boxed warning must convey the boxed-warning risk with prominence comparable to benefit claims, and reminder ads are not permitted for these drugs.

FDA OPDP Help-Seeking / Disease Awareness Ads

Disease-awareness ads from drug firms may discuss a condition and urge a doctor visit but must not name, cue or point to a specific drug; if they do, they become product ads needing risk information.

FDA OPDP Off-Label Promotion Prohibition

Drug firms may not promote prescription drugs for unapproved uses; scientific information on unapproved uses may go to HCPs only if separate from promotion and accompanied by the disclosures in FDA's 2025 guidance.

FDA OPDP Social Media Pharma Marketing

Social and character-limited posts that name a prescription drug and its benefit must state the most serious risks in the post and link to complete risk information.

Get a free homepage compliance scan